Peter Bader
University Children's Hospital
Department of Pediatric Hematology and Oncology
Hoppe-Seyler-Strasse 1
D-72070 Tübingen
Germany
Name/email consistency: high
- How and when should we monitor chimerism after allogeneic stem cell transplantation?. Bader, P., Niethammer, D., Willasch, A., Kreyenberg, H., Klingebiel, T. Bone Marrow Transplant. (2005)
- Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective. Bader, P., Kreyenberg, H., Hoelle, W., Dueckers, G., Kremens, B., Dilloo, D., Sykora, K.W., Niemeyer, C., Reinhardt, D., Vormoor, J., Gruhn, B., Lang, P., Greil, J., Handgretinger, R., Niethammer, D., Klingebiel, T., Beck, J.F. Bone Marrow Transplant. (2004)
- Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?. Bader, P., Kreyenberg, H., Hoelle, W., Dueckers, G., Handgretinger, R., Lang, P., Kremens, B., Dilloo, D., Sykora, K.W., Schrappe, M., Niemeyer, C., Von Stackelberg, A., Gruhn, B., Henze, G., Greil, J., Niethammer, D., Dietz, K., Beck, J.F., Klingebiel, T. J. Clin. Oncol. (2004)
- WT1 gene expression: useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?. Bader, P., Niemeyer, C., Weber, G., Coliva, T., Rossi, V., Kreyenberg, H., Gerecke, A., Biondi, A. Eur. J. Haematol. (2004)
- Characterization of lineage-specific chimaerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse. Bader, P., Stoll, K., Huber, S., Geiselhart, A., Handgretinger, R., Niemeyer, C., Einsele, H., Schlegel, P.G., Niethammer, D., Beck, J., Klingebiel, T. Br. J. Haematol. (2000)